Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

A randomized trial in patients undergoing percutaneous coronary angioplasty: roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae.

Kaehler J, Haar A, Schaps KP, Gaede A, Carstensen M, Schalwat I, Koester R, Laufs R, Meinertz T, Terres W.

Am Heart J. 2005 Nov;150(5):987-93.

PMID:
16290983
2.

A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.

Polywka S, Duttmann H, Lübben F, Laufs R, Feldner J.

Methods Mol Biol. 2005;304:229-43.

PMID:
16061980
3.

Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.

Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH.

Intervirology. 2005;48(4):213-5.

PMID:
15920344
4.
5.
6.

Disseminated Mycobacterium haemophilum infection as initial manifestation of AIDS.

Stürenburg EE, Horstkotte MA, Aberle J, Meyer K, Richter E, Laufs R, Sobottka I.

Tuberculosis (Edinb). 2004;84(6):341-5. Review.

PMID:
15525556
7.
8.

Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process.

Schroter M, Zollner B, Laufs R, Feucht HH.

J Infect Dis. 2004 Sep 15;190(6):1199-200; author reply 1200-1. No abstract available.

PMID:
15319872
9.

[Viral hepatitis in children and adolescence].

Burdelski M, Wirth S, Laufs R.

Z Gastroenterol. 2004 Aug;42(8):731-3. Review. German. No abstract available.

PMID:
15314725
10.

A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.

Stürenburg E, Kühn A, Mack D, Laufs R.

J Antimicrob Chemother. 2004 Aug;54(2):406-9. Epub 2004 Jun 16.

PMID:
15201232
11.

Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.

Stürenburg E, Sobottka I, Noor D, Laufs R, Mack D.

J Antimicrob Chemother. 2004 Jul;54(1):134-8. Epub 2004 May 18.

PMID:
15150168
12.

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

Hepatology. 2004 Jan;39(1):42-50.

PMID:
14752821
13.

Pet snakes as a reservoir for Salmonella enterica subsp. diarizonae (Serogroup IIIb): a prospective study.

Schröter M, Roggentin P, Hofmann J, Speicher A, Laufs R, Mack D.

Appl Environ Microbiol. 2004 Jan;70(1):613-5.

14.

Multiple infections with different HCV genotypes: prevalence and clinical impact.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

J Clin Virol. 2003 Jul;27(2):200-4.

PMID:
12829042
15.

A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Feucht HH.

J Clin Virol. 2003 May;27(1):69-73.

PMID:
12727531
16.
17.

In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.

Sobottka I, Cachovan G, Stürenburg E, Ahlers MO, Laufs R, Platzer U, Mack D.

Antimicrob Agents Chemother. 2002 Dec;46(12):4019-21.

18.

[Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].

Laufs R, Polywka S, Feucht HH, Schröter M, Zöllner B, Oehler G.

Anaesthesist. 2002 Nov;51(11):884-9. Review. German.

PMID:
12434261
19.

Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Sterneck M, Fischer L, Feucht HH.

J Viral Hepat. 2002 Nov;9(6):455-9.

PMID:
12431209
20.

SENV-H viremia and liver transplantation: significant increase of the prevalence.

Schröter M, Laufs R, Sterneck M, Fischer L, Knödler B, Schäfer P, Zöllenr B, Feucht HH.

Blood. 2002 Aug 15;100(4):1518-9. No abstract available.

21.

Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.

Ludwig K, Grabhorn E, Bitzan M, Bobrowski C, Kemper MJ, Sobottka I, Laufs R, Karch H, Müller-Wiefel DE.

Pediatr Res. 2002 Aug;52(2):307-13.

PMID:
12149511
22.

In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi.

Sobottka I, Bartscht K, Schäfer P, Weitzel T, Schottelius J, Kock N, Laufs R.

Parasitol Res. 2002 May;88(5):451-3.

PMID:
12049463
23.

Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Schröter M, Zöllner B, Schäfer P, Landt O, Lass U, Laufs R, Feucht HH.

J Clin Microbiol. 2002 Jun;40(6):2046-50.

24.

Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin linked to carbapenem resistance.

Stürenburg E, Sobottka I, Mack D, Laufs R.

Int J Med Microbiol. 2002 Mar;291(8):649-54.

PMID:
12008919
25.

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH.

J Clin Microbiol. 2002 May;40(5):1866-8.

26.

Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Ludwig K, Sarkim V, Bitzan M, Karmali MA, Bobrowski C, Ruder H, Laufs R, Sobottka I, Petric M, Karch H, Müller-Wiefel DE.

J Clin Microbiol. 2002 May;40(5):1773-82.

27.

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH.

Clin Infect Dis. 2002 May 1;34(9):1273-7. Epub 2002 Apr 2.

PMID:
11941556
28.

Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy.

Zöllner B, Schäfer P, Feucht HH, Schröter M, Petersen J, Laufs R.

J Med Virol. 2001 Dec;65(4):659-63.

PMID:
11745928
29.

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.

Albrecht D, Zöllner B, Feucht HH, Lorenzen T, Laufs R, Stoehr A, Plettenberg A.

J Clin Virol. 2002 Feb;24(1-2):93-8.

PMID:
11744433
30.

Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Virol. 2001 Dec;23(1-2):57-63.

PMID:
11595584
31.

Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients.

Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.

J Med Virol. 2001 Sep;65(1):85-9.

PMID:
11505448
32.

Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.

Polywka S, Feldner J, Duttmann H, Laufs R.

Clin Lab. 2001;47(7-8):351-6.

PMID:
11499796
33.

Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.

Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.

J Med Virol. 2001 Jul;64(3):320-4.

PMID:
11424121
34.

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.

Zöllner B, Feucht HH, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R.

AIDS. 2001 May 4;15(7):935-6. No abstract available.

PMID:
11399967
35.

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH.

Lancet. 2001 Mar 24;357(9260):934-5.

PMID:
11289355
36.

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

J Clin Microbiol. 2001 Apr;39(4):1665-8.

37.

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.

Zöllner B, Feucht HH, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2001 Apr;21(1):37-45.

PMID:
11255096
38.

Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

Nephron. 2001 Feb;87(2):139-42.

PMID:
11244308
39.

Acute and long-term humoral immunity following active immunization of rabbits with inactivated spores of various Encephalitozoon species.

Sobottka I, Iglauer F, Schüler T, Schmetz C, Visvesvara GS, Albrecht H, Schwartz DA, Pieniazek NJ, Bartscht K, Laufs R, Schottelius J.

Parasitol Res. 2001 Jan;87(1):1-6.

PMID:
11199842
40.

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2001 Feb;39(2):765-8.

41.

Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient.

Horstkotte MA, Sobottka I, Schewe CK, Schäfer P, Laufs R, Rüsch-Gerdes S, Niemann S.

J Clin Microbiol. 2001 Jan;39(1):406-7.

42.

Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university pediatric hospital.

Elsner HA, Sobottka I, Feucht HH, Harps E, Haun C, Mack D, Ganschow R, Laufs R, Kaulfers PM.

Int J Hyg Environ Health. 2000 Oct;203(2):147-52.

PMID:
11109567
43.

In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note.

Zöllner B, Stoehr A, Plettenberg A, Feucht H, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2000 Sep 1;17(3):183-8.

PMID:
10996115
44.

False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation.

Schäfer P, Tenschert W, Schröter M, Gutensohn K, Laufs R.

J Clin Microbiol. 2000 Sep;38(9):3249-53.

45.

Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients.

Schäfer P, Tenschert W, Cremaschi L, Schröter M, Gutensohn K, Laufs R.

J Med Virol. 2000 Aug;61(4):488-96.

PMID:
10897068
46.

Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates.

Elsner HA, Sobottka I, Mack D, Claussen M, Laufs R, Wirth R.

Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):39-42.

PMID:
10706178
47.

Inter- and intra-species karyotype variations among microsporidia of the genus Encephalitozoon as determined by pulsed-field gel electrophoresis.

Sobottka I, Albrecht H, Visvesvara GS, Pieniazek NJ, Deplazes P, Schwartz DA, Laufs R, Elsner HA.

Scand J Infect Dis. 1999;31(6):555-8.

PMID:
10680984
48.

In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R, Mack D.

Chemotherapy. 2000 Mar-Apr;46(2):104-10.

PMID:
10671760
49.

Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Schröter M, Polywka S, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2000 Feb;38(2):745-7.

50.

Low risk of vertical transmission of hepatitis C virus by breast milk.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

Clin Infect Dis. 1999 Nov;29(5):1327-9.

PMID:
10524987

Supplemental Content

Support Center